CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 3.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,457 | -19.5% | 25,909 | -60.0% | 0.00% | – |
| Q4 2022 | $14,236 | -72.1% | 64,795 | -53.4% | 0.00% | – |
| Q3 2022 | $51,000 | +112.5% | 139,077 | +279.3% | 0.00% | – |
| Q2 2022 | $24,000 | -44.2% | 36,665 | -29.4% | 0.00% | – |
| Q1 2022 | $43,000 | -84.5% | 51,942 | -78.6% | 0.00% | – |
| Q4 2021 | $277,000 | -51.9% | 242,675 | +5.3% | 0.00% | – |
| Q3 2021 | $576,000 | +94.6% | 230,381 | +130.8% | 0.00% | – |
| Q2 2021 | $296,000 | -50.6% | 99,803 | -41.4% | 0.00% | – |
| Q1 2021 | $599,000 | -29.1% | 170,443 | -4.1% | 0.00% | – |
| Q4 2020 | $845,000 | -40.6% | 177,792 | -39.3% | 0.00% | – |
| Q3 2020 | $1,423,000 | +140.4% | 292,841 | +60.8% | 0.00% | – |
| Q2 2020 | $592,000 | +565.2% | 182,127 | +946.6% | 0.00% | – |
| Q1 2020 | $89,000 | +78.0% | 17,402 | +57.9% | 0.00% | – |
| Q4 2019 | $50,000 | -13.8% | 11,019 | -34.5% | 0.00% | – |
| Q1 2014 | $58,000 | – | 16,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |